Altshuler Shaham’s Madrigal Pharmaceuticals MDGL Stock Holding History

Altshuler Shaham’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,135	Closed	-$153K	–	507
2022 Q2	$153K	Hold	2,135	–	–	﹤0.01%	138
2022 Q1	$209K	Sell	2,135 -3,120	-59%	-$263K	﹤0.01%	212
2021 Q4	$445K	Hold	5,255	–	–	﹤0.01%	204
2021 Q3	$422K	Hold	5,255	–	–	﹤0.01%	205
2021 Q2	$512K	Hold	5,255	–	–	﹤0.01%	199
2021 Q1	$615K	Hold	5,255	–	–	0.01%	116
2020 Q4	$584K	Sell	5,255 -2,400	-31%	-$293K	0.01%	97
2020 Q3	$909K	Hold	7,655	–	–	0.02%	77
2020 Q2	$867K	Hold	7,655	–	–	0.03%	66
2020 Q1	$511K	Buy	7,655 +203	+3%	+$16.9K	0.02%	86
2019 Q4	$679K	Hold	7,452	–	–	0.02%	88
2019 Q3	$648K	Buy	7,452 +83	+1%	+$7.79K	0.03%	82
2019 Q2	$772K	Buy	7,369 +356	+5%	+$38.1K	0.03%	90
2019 Q1	$878K	Buy	7,013 +2,286	+48%	+$284K	0.04%	89
2018 Q4	$533K	Sell	4,727 -13	-0.3%	-$2.01K	0.02%	101
2018 Q3	$1.01M	Buy	+4,740	New	+$1.19M	0.05%	87

Other funds holding MDGL

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Altshuler Shaham's MDGL Position: Q3 2022 in Review

Altshuler Shaham sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2022, closing a stake of 2,135 shares — an estimated $153K sold.

Altshuler Shaham first reported a position in MDGL in Q3 2018 and held it in 16 quarters. The position peaked at $1.01M in Q3 2018. 135 funds tracked by Wall St. Rank hold MDGL as of Q3 2022.

Altshuler Shaham reported no remaining Madrigal Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Altshuler Shaham sold 2,135 Madrigal Pharmaceuticals shares in Q3 2022, an estimated $153K.
Altshuler Shaham first reported a position in Madrigal Pharmaceuticals in Q3 2018 and held it in 16 quarters.
Altshuler Shaham's Madrigal Pharmaceuticals position peaked at $1.01M in Q3 2018.
135 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2022.

Based on Altshuler Shaham's 13F filing for Q3 2022, filed 14 Nov 2022.